Rushing to the maximum dose is the most common reason patients end up miserable and quit
However, certain medical conditions require specific precautions
*In a 68- and 72-week clinical trial studying Wegovy (2.4 mg) in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20%, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)
Lyophilised retatrutide stored at -20C retains stability over the long term, but reconstituted solutions have a significantly shorter viable window typically four to six weeks under refrigeration at 2-8C
According to the University of Colorado Anschutz researchers, women with PMOS frequently face a difficult choice between therapies that improve reproductive symptoms and those that target obesity and metabolic health